FDA Rule Would Allow Swift Drug Label Updates

WASHINGTON — The Food and Drug Administration is issuing a proposed rule that would allow generic drug manufacturers to independently update and distribute product labeling, just as brand name manufacturers are permitted to do now.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.